An Oncoming Wave of 70+ Coding Revisions Is Approaching. Starting from November 1st, the American Medical Association is eliminating nearly all of the COVID-19 vaccine-related CPT® codes that were developed over the past several years. Instead, there will be a more concise set of product codes and a solitary administration code to replace them. What […]
Age determines who qualifies for the bivalent formulations from Pfizer and Moderna. On Aug. 31, 2022, the U.S. Food and Drug Administration (FDA) amended the emergency use authorizations (EUAs) of the Moderna and Pfizer-BioNTech COVID-19 vaccines to include updated booster bivalent formulations. These latest formulations include messenger RNA components to help build immunity against both […]
The American Medical Association (AMA) has created three new CPT® codes to report the administration of the Moderna COVID-19 vaccine for patients 6 through 11 years. The new codes are effective June 17, 2022. Note These New Moderna Admin Codes For children ages 6 through 11 years, report the Moderna vaccine with existing CPT® code […]
The ability to rapidly and accurately report such granular detail requires a robust data infrastructure. Instrumental to this infrastructure are the specific AMA Current Procedural Terminology (CPT®) product and administrative codes related to COVID-19 vaccines. Long described as the “common language of medicine,” the CPT code set is kept current through the work of the CPT Editorial […]
New COVID-19 vaccine status codes, changes and corrections to the 2022 CPT code set, Medicare Physician Fee Schedule (MPFS) payment changes, and prior authorization code list changes — that’s what’s on the agenda this month. Read all about it! 3 New Codes Improve COVID-19 Vaccination Status An April 1, 2022, update to the 2022 ICD-10-CM […]
AMA updated the CPT code set to accommodate the new mix-and-match COVID-19 vaccine booster strategy endorsed by the federal government. The update comes on the heels of a decision from the Federal Drug Administration (FDA) to authorize booster doses of Janssen’s COVID-19 vaccine. The federal agency has recommended a booster dose of the vaccine […]
To prepare for potential FDA authorization, AMA has released new CPT codes for pediatric doses of the Pfizer COVID-19 vaccine. In September 2021, Pfizer and BioNTech shared the results of a Phase 2/3 clinical trial in which two doses of the vaccine elicited a strong immune response in children ages 5 to 11. Following the […]
The American Medical Association’s (AMA’s) CPT® Editorial Panel has released eight new COVID-19-related codes to report a new formulation of the Pfizer vaccine, a Moderna booster vaccine, and a Pfizer booster using either the new or old formulation. These codes are in addition to the four new CPT codes released last month and the many […]